연구동향 분석
박사

The contribution of chronic kidney disease measures to cause-specific mortality and morbidity : 만성신장질환 요인이 특정원인질환 사망 및 발생에 미치는 영향

Mok, Yejin 2015년

논문상세정보
인용/피인용
' The contribution of chronic kidney disease measures to cause-specific mortality and morbidity : 만성신장질환 요인이 특정원인질환 사망 및 발생에 미치는 영향' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • egfr
  • morbodity
  • mortality
  • proteinuria
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
341 0

0.0%

' The contribution of chronic kidney disease measures to cause-specific mortality and morbidity : 만성신장질환 요인이 특정원인질환 사망 및 발생에 미치는 영향' 의 참고문헌

  • van der Velde M, Matsushita K, Coresh J, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011;79(12):1341-52.
  • van Buuren S, Boshuizen HC and Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999;18(6):681-94.
  • Zandbergen AA, Vogt L, de Zeeuw D, et al. Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria. Diabetes Care 2007;30(12):3119-21.
  • World Health Organization. Causes of death: Mortality and health status. WHO data and statistics. http://apps.who.int/gho/data/node.main.CODNUMBER?lang=en: WHO Statistical Information System (Accessed July 28 2014).
  • Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol 2009;20(6):1341-50.
  • Winkler V, Ott JJ and Becher H. Reliability of coding causes of death with ICD-10 in Germany. Int J Public Health 2010;55(1):43-8.
  • White IR, Royston P and Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011;30(4):377-99.
  • Weng PH, Hung KY, Huang HL, et al. Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 2011;6(5):1121-8.
  • Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371(9631):2173-82.
  • Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15(5):1307-15.
  • Wang HE, Gamboa C, Warnock DG, et al. Chronic kidney disease and risk of death from infection. Am J Nephrol 2011;34(4):330-6.
  • United States Renal Data System, 2014 Annual Data Report: Epidemiology of Kidney Disease in the United State. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014
  • Turin TC, James MT, Jun M, et al. Short-term change in eGFR and risk of cardiovascular events. J Am Heart Assoc 2014;3(5):e000997.
  • Turin TC, Coresh J, Tonelli M, et al. Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant 2012;27(10):3835-43.
  • Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17(7):2034-47.
  • Stevens PE, O'Donoghue DJ, de Lusignan S, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007;72(1):92-9.
  • Stehouwer CD, Gall MA, Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002;51(4):1157-65.
  • Song YM. and Sung J. Body mass index and mortality: a twelve-year prospective study in Korea. Epidemiology 2001;12(2):173-9.
  • Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352(20):2049-60.
  • Sawyer N, Wadsworth J, Wijnen M, et al. Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J (Clin Res Ed) 1988;296(6632):1295-8.
  • Rifkin DE, Shlipak MG, Katz R, et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008;168(20):2212-8.
  • Perkins RM, Bucaloiu ID, Kirchner HL, et al. GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 2011;6(8):1879-86.
  • Pedersen LM and Milman N. Microalbuminuria in patients with lung cancer. Eur J Cancer 1998;34(1):76-80.
  • National Bureau of Statistics. Results of the 2010 population and housing census. Seoul, Republic of Korea
  • Nagata M, Ninomiya T, Kiyohara Y, et al. Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort studies in Japan. Am J Epidemiol 2013;178(1):1-11.
  • Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375(9731):2073-81.
  • Matsushita K, Selvin E, Bash LD, et al. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 2009;20(12):2617-24.
  • Mahmoodi BK, Yatsuya H, Matsushita K, et al. Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective communitybased cohorts. Stroke 2014;45(7):1925-31.
  • Lu TH, Lee MC and Chou MC. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol 2000;29(2):336-43.
  • Lowrance WT, Ordonez J, Udaltsova N, et al. CKD and the Risk of Incident Cancer. J Am Soc Nephrol 2014;25(10):2327-34.
  • Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80(1):17-28.
  • Leung WK, Wu MS, Kakugawa Y, et al. Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008;9(3):279-87.
  • Lee DH, Shin HR, Ahn DH, et al. Accuracy of cancer death certificates in Korea. A comparison between diagnoses in the central cancer registry and certified underlying causes of death. J Korean Cancer Assoc 2000;32(1):210-9.
  • Kovesdy CP, George SM, Anderson JE, et al. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr 2009;90(2):407-14.
  • Konta T, Hao Z, Takasaki S, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11(1):51- 5.
  • Kidney Disease: Improving Global Outcomes, KDIGO 2012 clinical practice guideline for evaluation and management of chronic kidney disease (New York, NY: Nature Publ. Group, 2013).
  • Jorgensen L, Heuch I, Jenssen T, et al. Association of albuminuria and cancer incidence. J Am Soc Nephrol 2008;19(5):992-8.
  • Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013;382(9888):260-72.
  • Jee SH, Batty GD, Jang Y, et al. The Korean Heart Study: rationale, objectives, protocol, and preliminary results for a new prospective cohort study of 430,920 men and women. Eur J Prev Cardiol 2013;21(12):1484-92.
  • Janu, N, Vacher LV, Karie S, et al. Vaccination and chronic kidney disease. Nephrol Dial Transplant 2008;23(3):800-7.
  • Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009;13(6):621-30.
  • Iff S, Craig JC, Turner R, et al. Reduced estimated GFR and cancer mortality. Am J Kidney Dis 2014;63(1):23-30.
  • Herget-Rosenthal S, Trabold S, Pietruck F, et al. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 2000;20(2):97-102.
  • Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010;303(5):423-9.
  • Harteloh P, de Bruin K and Kardaun J. The reliability of cause-of-death coding in The Netherlands. Eur J Epidemiol 2010;25(8):531-8.
  • Hallan SI., Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012;308(22): 2349-60.
  • Hallan S, Astor B, Romundstad S, et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 2007;167(22):2490-6.
  • Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013;382(9889):339-352.
  • Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005;16(12):3728-3735.
  • Franses JW, Drosu NC, Gibson WJ, et al. Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis. Int J Cancer 2013;133(6):1334-44.
  • Fine JP and Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. Journal of the American Statistical Association 1999;94(446):496-509.
  • Di Angelantonio E, Chowdhury R, Sarwar N, et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010;341:c4986.
  • Davis AM and Cifu AS. Lung cancer screening. JAMA 2014;312(12):1248-9.
  • Coussens LM and Werb Z. Inflammation and cancer. Nature 2002;420(6917):860-7.
  • Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298(17):2038-47.
  • Chun JH. and Lee KS. Actual Conditions and Pitfalls of Death Statistics Based on the Current Death Registration System in Korea. Korean J Epidemiol 2000;22(2):124-35.
  • Arora P, Vasa P, Brenner D, et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013;185(9):E417-23.
  • Al-Aly Z, Zeringue A, Fu J, et al. Rate of kidney function decline associates with mortality. J Am Soc Nephrol 2010;21(11):1961-9.
  • Aguilar MI., O'Meara E S, Seliger S, et al. Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology 2010;75(15):1343-50.